Green tea polyphenols mitigate bone loss of female rats in a chronic inflammation-induced bone loss model

Journal of Nutritional Biochemistry

Volumn 21, Issue 10, 2010, Pages 968-974

  Shen, Chwan Li ^a,b   Yeh, James K ^c   Cao, Jay J ^d   Tatum, Owatha L ^b   Dagda, Raul Y ^a   Wang, Jia Sheng ^e  

^a TEXAS TECH UNIVERSITY HEALTH SCIENCES CENTER SCHOOL OF MEDICINE   (United States)

^b TEXAS TECH UNIVERSITY HEALTH SCIENCES CENTER   (United States)

^c WINTHROP UNIVERSITY HOSPITAL   (United States)

^d GRAND FORKS HUMAN NUTRITION RESEARCH CENTER   (United States)

^e UNIVERSITY OF GEORGIA   (United States)

Author keywords

Bone; Dietary supplement; Inflammation; Oxidative stress; Tea

Indexed keywords

8 HYDROXYDEOXYGUANOSINE; ACID PHOSPHATASE TARTRATE RESISTANT ISOENZYME; CYCLOOXYGENASE 2; EPICATECHIN; EPIGALLOCATECHIN; GUANOSINE TRIPHOSPHATE; LIPOPOLYSACCHARIDE; MESSENGER RNA; OSTEOCALCIN; PLACEBO; POLYPHENOL DERIVATIVE; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIOAVAILABILITY; BODY WEIGHT; BONE DENSITY; BONE MINERAL; BONE TURNOVER; CHRONIC INFLAMMATION; CONTROLLED STUDY; DIET SUPPLEMENTATION; DUAL ENERGY X RAY ABSORPTIOMETRY; FEMALE; FEMUR; NONHUMAN; OSTEOLYSIS; OXIDATIVE STRESS; PROTEIN EXPRESSION; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TEA;

ANIMALS; BASE SEQUENCE; BIOLOGICAL AVAILABILITY; BODY WEIGHT; BONE DISEASES, METABOLIC; BONE REMODELING; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CHRONIC DISEASE; CYCLOOXYGENASE 2; DEOXYGUANOSINE; DISEASE MODELS, ANIMAL; DNA PRIMERS; DRINKING BEHAVIOR; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FLAVONOIDS; INFLAMMATION; PHENOLS; RATS; RNA, MESSENGER; TEA; TUMOR NECROSIS FACTOR-ALPHA;

RATTUS;

EID: 77956648224     PISSN: 09552863     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jnutbio.2009.08.002     Document Type: Article

References (72)

1. Van Dyke T.E., Serhan C.N. Resolution of inflammation: a new paradigm for the pathogenesis of periodontal diseases. J Dent Res 2003, 82:82-90.
2. Mann S.T., Stracke H., Lange U., Klor H.U., Teichmann J. Alternations of bone mineral density and bone metabolism in patients with various grades of chronic pancreatitis. Metabolism 2003, 52:579-585.
3. Bernstein C.N., Leslie W.D., Taback S.P. Bone density in a population-based cohort or premenopausal adult women with early onset inflammatory bowel disease. Am J Gastroenterol 2003, 98:1094-1100.
4. Romas E., Gillespie M.T., Martin T.J. Involvement of receptor activator of NFkappaB ligand and tumor necrosis factor-alpha in bone destruction in rheumatoid arthritis. Bone 2002, 30(2):340-346. Review.
5. Uaratanawong S., Deesomchoke U., Lertmaharit S., Uaratanawong S. Bone mineral density in premenopausal women with systemic lupus erythematosus. J Rheumatol 2003, 30(11):2365-2368.
6. 2-mediated bone resorption associated with inflammation. J Exp Med 2003, 197(10):1303-1310.
7. Cochran D.L. Inflammation and bone loss in periodontal disease. J Periodontol 2008, 79(8 Suppl):1569-1576.
8. Boulos P., Ioannidis G., Adachi J.D. Glucocorticoid-induced osteoporosis. Curr Rheumatol Rep 2000, 2(1):53-61.
9. Hofbauer L.C., Brueck C.C., Shanahan C.M., Schoppet M., Dobnig H. Vascular calcification and osteoporosis-from clinical observation towards molecular understanding. Osteoporos Int 2007, 18(3):251-259. Review.
10. Shen C.L., Wang P., Guerrieri J., Yeh J.K., Wang J.S. Protective effect of green tea polyphenols on bone loss in middle-aged female rats. Osteoporos Int 2008, 19(7):979-990.
11. Shen C.L., Yeh J.K., Stoecker B.J., Chyu M.C., Wang J.S. Green tea polyphenols mitigate deterioration of bone microarchitecture in middle-aged female rats. Bone 2009, 44(4):684-690.
12. Maggio D., Barabani M., Pierandrei M., Polidori M.C., Catani M., Mecocci P., et al. Marked decrease in plasma antioxidants in aged osteoporotic women: results of a cross-sectional study. J Clin Endocrinol Metab 2003, 88(4):1523-1527.
13. Ozgocmen S., Kaya H., Fadillioglu E., Aydogan R., Yilmaz Z. Role of antioxidant systems, lipid peroxidation, and nitric oxide in postmenopausal osteoporosis. Mol Cell Biochem 2007, 295(1-2):45-52.
14. Finkel T., Holbrook N.J. Oxidants, oxidative stress and the biology of ageing. Nature 2000, 408(6809):239-247.
15. Banfi G., Iorio E.L., Corsi M.M. Oxidative stress, free radicals and bone remodeling. Clin Chem Lab Med 2008, 46(11):1550-1555. Review.
16. Mody N., Parhami F., Saraflan T.A., Demer L.L. Oxidative stress modulates osteoblastic differentiation of vascular and bone cells. Free Radic Biol Med 2001, 31:509-519.
17. Muthusami S., Ramachandran I., Muthusamy B., Vasudevan G., Prabhu V., Subramaniam V., et al. Ovariectomy induces oxidative stress and impairs bone antioxidant system in adult rats. Clin Chim Acta 2005, 360(1-2):81-86.
18. 2 while making cholesterol. Endocrinology 2008, 149(7):3264-3266.
19. Garrett J.R., Boyce B.F., Oreffo R.O., Bonewald L., Poser J., Mundy G.R. Oxygen-derived free radicals stimulate osteoclastic bone resorption in rodent bone in vitro and in vivo. J Clin Invest 1990, 85:632-639.
20. Watkins B.A., Hannon K., Ferruzzi M., Li Y. Dietary PUFA and flavonoids as deterrents for environmental pollutants. J Nutr Biochem 2007, 18(3):196-205.
21. Cabrera C., Artacho R., Giménez R. Beneficial effects of green tea-a review. J Am Coll Nutr 2006, 25(2):79-99.
22. Muraki S., Yamamoto S., Ishibashi H., Oka H., Yoshimura N., Kawaguchi H., et al. Diet and lifestyle associated with increased bone mineral density: cross-sectional study of Japanese elderly women at an osteoporosis outpatient clinic. J Orthop Sci 2007, 12(4):317-320.
23. Devine A., Hodgson J.M., Dick I.M., Prince R.L. Tea drinking is associated with benefits on bone density in older women. Am J Clin Nutr 2007, 86(4):1243-1247.
24. Chen Z., Pettinger M.B., Ritenbaugh C., LaCroix A.Z., Robbins J., Caan B.J., et al. Habitual tea consumption and risk of osteoporosis: a prospective study in the women's health initiative observational cohort. Am J Epidemiol 2003, 158(8):772-781.
25. Wu C.H., Yang Y.C., Yao W.J., Lu F.H., Wu J.S., Chang C.J. Epidemiological evidence of increased bone mineral density in habitual tea drinkers. Arch Intern Med 2002, 162(9):1001-1006.
26. Vali B., Rao L.G., El-Sohemy A. Epigallocatechin-3-gallate increases the formation of mineralized bone nodules by human osteoblast-like cells. J Nutr Biochem 2007, 18(5):341-347.
27. Takai S., Matsushima-Nishiwaki R., Adachi S., Natsume H., Minamitani C., Mizutani J., et al. (-)-Epigallocatechin gallate reduces platelet-derived growth factor-BB-stimulated interleukin-6 synthesis in osteoblasts: suppression of SAPK/JNK. Mediators Inflamm 2008, 291808. Epub 2009 Jan 12.
28. Chen C.H., Ho M.L., Chang J.K., Hung S.H., Wang G.J. Green tea catechin enhances osteogenesis in a bone marrow mesenchymal stem cell line. Osteoporos Int 2005, 16(12):2039-2045.
29. Smith B.J., Lerner M.R., Bu S.Y., Lucas E.A., Hanas J.S., Lightfoot S.A., et al. Systemic bone loss and induction of coronary vessel disease in a rat model of chronic inflammation. Bone 2006, 38(3):378-386.
30. Zhu B.T., Taneja N., Loder D.P., Balentine D.A., Conney A.H. Effects of tea polyphenols and flavonoids on liver microsomal glucuronidation of estradiol and estrone. J Steroid Biochem Mol Biol 1998, 64(3-4):207-215.
31. Haque A.M., Hashimoto M., Katakura M., Tanabe Y., Hara Y., Shido O. Long-term administration of green tea catechins improves spatial cognition learning ability in rats. J Nutr 2006, 136(4):1043-1047.
32. 2 and residronate on bone formation and resorption, osteocyte lacunar system, and porosity in the cortical bone of glucocorticoid-treated rats. Calcif Tissue Int 2008, 83:121-128.
33. Sánchez-Lemus E., Benicky J., Pavel J., Larrayoz I.M., Zhou J., Baliova M., et al. AT1 blockade reduces the lipopolysaccharide-induced innate immune response in rat spleen. Am J Physiol Regul Integr Comp Physiol 2009, 296(5):R1376-R1384.
34. Shen C.L., Yeh J.K., Stoecker B.J., Samathanam C., Graham S., Dunn D.M., et al. Green tea polyphenols protects bone microarchitecture in female rats with chronic inflammation-induced bone loss. JBMR 2008, 23:s458.
35. Droke E.A., Hager K.A., Lerner M.R., Lightfoot S.A., Stoecker B.J., Brackett D.J., et al. Soy isoflavones avert chronic inflammation-induced bone loss and vascular disease. J Inflamm (Lond) 2007, 4:17.
36. Wang J.S., Luo H., Wang P., Tang L., Yu J., Huang T., et al. Validation of green tea polyphenol biomarkers in a phase II human intervention trial. Food Chem Toxicol 2008, 46(1):232-240.
37. Luo H., Tang L., Tang M., Billam M., Huang T., Yu J., et al. Phase IIa chemoprevention trial of green tea polyphenols in high-risk individuals of liver cancer: modulation of urinary excretion of green tea polyphenols and 8-hydroxydeoxyguanosine. Carcinogenesis 2006, 27(2):262-268.
38. Lee M.J., Maliakal P., Chen L., Meng X., Bondoc F.Y., Prabhu S., et al. Pharmacokinetics of tea catechins after ingestion of green tea and (-)-epigallocatechin-3 gallate by humans: formation of different metabolites and individual variability. Cancer Epidemiol Biomarkers Prev 2002, 11(10 Pt 1):1025-1032.
39. Yun J.H., Pang E.K., Kim C.S., Yoo Y.J., Cho K.S., Chai J.K., et al. Inhibitory effects of green tea polyphenol (-)-epigallocatechin gallate on the expression of matrix metalloproteinase-9 and on the formation of osteoclasts. J Periodontal Res 2004, 39(5):300-307.
40. Nakagawa H., Wachi M., Woo J.T., Kato M., Kasai S., Takahashi F., et al. Fenton reaction is primarily involved in a mechanism of (-)-epigallocatechin-3-gallate to induce osteoclastic cell death. Biochem Biophys Res Commun 2002, 292(1):94-101.
41. Nakagawa H., Hasumi K., Takami M., Aida-Hyugaji S., Woo J.T., Nagai K., et al. Identification of two biologically crucial hydroxyl groups of (-)-epigallocatechin gallate in osteoclast culture. Biochem Pharmacol 2007, 73(1):34-43.
42. Hafeez B.B., Ahmed S., Wang N., Gupta S., Zhang A., Haqqi T.M. Green tea polyphenols induced apoptosis in human osteosarcoma SAOS-2 cells involves a caspase-dependent mechanism with downregulation of nuclear factor-kappaB. Toxicol Appl Pharmacol 2006, 216(1):11-19.
43. Lin R.W., Chen C.H., Wang Y.H., Ho M.L., Hung S.H., Chen I.S., et al. (-)-Epigallocatechin gallate inhibition of osteoclastic differentiation via NF-kappaB. Biochem Biophys Res Commun 2009, 379(4):1033-1037.
44. Roomi M.W., Ivanov V., Kalinovsky T., Niedzwiecki A., Rath M. Antitumor effect of nutrient synergy on human osteosarcoma cells U-2OS, MNNG-HOS and Ewing's sarcoma SK-ES.1. Oncol Rep 2005, 13(2):253-257.
45. Nakagawa H., Hasumi K., Woo J.T., Nagai K., Wachi M. Generation of hydrogen peroxide primarily contributes to the induction of Fe(II)-dependent apoptosis in Jurkat cells by (-) epigallocatechin gallate. Carcinogenesis 2004, 25(9):1567-1574.
46. Islam S., Islam N., Kermode T., Johnstone B., Mukhtar H., Moskowitz R.W., et al. Involvement of caspase-3 in epigallocatechin-3-gallate-mediated apoptosis of human chondrosarcoma cells. Biochem Biophys Res Commun 2001, 270(3):793-797.
47. Delaissé J.M., Eeckhout Y., Vaes G. Inhibition of bone resorption in culture by (+)-catechin. Biochem Pharmacol 1986, 35(18):3091-3094.
48. Mundy G.R. Cytokine and growth factors in the regulation of bone remodeling. J Bone Miner Res 2003, 8(suppl 2):S505-S510.
49. Raisz L.G. Pathogenesis of osteoporosis: concepts, conflicts, and prospects. J Clin Invest 2005, 115(12):3318-3325.
50. Cohen S. Role of RANK ligand in normal and pathologic bone remodeling and the therapeutic potential of novel inhibitory molecules in musculoskeletal diseases. Arthritis Rheum 2006, 55(1):15-18.
51. Ralston S.H., Ho L.P., Helfrich M.H., Grabowski P.S., Johnston P.W., Benjamin N. Nitric oxide: a cytokin-induced regulator of bone resorption. J Bone Miner Res 1995, 10:1040-1049.
52. Rauner M., Sipos W., Pietschmann P. Osteoimmunology. Int Arch Allergy Immunol 2006, 143(1):31-48.
53. Li L., Pettit A.R., Gregory L.S., Forwood M.R. Regulation of bone biology by prostaglandin endoperoxide H synthases (PGHS): a rose by any other name. Cytokine Growth Factor Rev 2006, 17(3):203-216.
54. Okada Y., Pilbeam C., Raisz L., Tanaka Y. Role of cyclooxygenase-2 in bone resorption. J UOEH 2003, 25(2):185-195.
55. 2 receptors EP2 and EP4 are down-regulated during differentiation of mouse osteoclasts from their precursors. J Biol Chem 2005, 280(25):24035-24042.
56. 2 strongly inhibits human osteoclast formation. Endocrinology 2005, 146(12):5204-5214.
57. 2 and EP receptors in the pathogenesis of rheumatoid arthritis and as a novel therapeutic strategy. Endocr Metab Immune Disord Drug Targets 2006, 6(4):383-394.
58. Watkins B.A., Li Y., Allen K.G., Hoffmann W.E., Seifert M.F. Dietary ratio of (n-6)/(n-3) polyunsaturated fatty acids alters the fatty acid composition of bone compartments and biomarkers of bone formation in rats. J Nutr 2000, 130(9):2274-2284.
59. 2 on osteoclast formation in spleen cell cultures: role of the EP2 receptor. J Bone Miner Res 2005, 20(1):23-29.
60. 2 on bone formation in cultured fetal rat calvariae: interaction with cortisol. Endocrinology 1990, 126(3):1654-1659.
61. Shen C.L., Yeh J.K., Rasty J., Li Y., Watkins B.A. Protective effect of dietary long-chain n-3 polyunsaturated fatty acids on bone loss in gonad-intact middle-aged male rats. Br J Nutr 2006, 95(3):462-468.
62. 2 stimulates collagen and non-collagen protein synthesis and prolyl hydroxylase activity in osteoblastic clone MC3T3-E1 cells. Biochem Biophys Res Commun 1985, 126(1):340-345.
63. 2 on the mineralization of a clonal osteoblastic cell line (MC3T3-E1). Arch Oral Biol 1999, 44(3):233-241.
64. Kong Y.Y., Penninger J.M. Molecular control of bone remodeling and osteoporosis. Exp Gerontol 2000, 35(8):947-956. Review.
65. Jones D.H., Kong Y.Y., Penninger J.M. Role of RANKL and RANK in bone loss and arthritis. Ann Rheum Dis 2002, 61(Suppl 2):ii32-ii39. Review.
66. Wei S., Teitelbaum S.L., Wang M.W., Ross F.P. Receptor activator of nuclear factor-kappa b ligand activates nuclear factor-kappa b in osteoclast precursors. Endocrinology 2001, 142(3):1290-1295.
67. Balga R., Wetterwald A., Portenier J., Dolder S., Mueller C., Hofstetter W. Tumor necrosis factor-alpha: alternative role as an inhibitor of osteoclast formation in vitro. Bone 2006, 39(2):325-335.
68. Armour K.J., Armour K.E., van't Hof R.J., Reid D.M., Wei X.Q., Liew F.Y., et al. Activation of the inducible nitric oxide synthase pathway contributes to inflammation-induced osteoporosis by suppressing bone formation and causing osteoblast apoptosis. Arthritis Rheum 2001, 44(12):2790-2796.
69. Dumitrescu A.L., Abd-El-Aleem S., Morales-Aza B., Donaldson L.F. A model of periodontitis in the rat: effect of lipopolysaccharide on bone resorption, osteoclast activity, and local peptidergic innervation. J Clin Periodontol 2004, 31(8):596-603.
70. Cao H., Kelly M.A., Kari F., Dawson H.D., Urban J.F., Coves S., et al. Green tea increases anti-inflammatory tristetraprolin and decreases pro-inflammatory tumor necrosis factor mRNA levels in rats. J Inflamm (Lond) 2007, 4:1.
71. Tang L., Tang M., Xu L., Luo H., Huang T., Yu J., et al. Modulation of aflatoxin biomarkers in human blood and urine by green tea polyphenols intervention. Carcinogenesis 2008, 29:411-417.
72. Deyhim F., Stoecker B.J., Brusewitz G.H., Devareddy L., Arjmandi B.H. Dried plum reverses bone loss in an osteopenic rat model of osteoporosis. Menopause 2005, 12(6):755-761.